Vontobel Holding’s Pulse Biosciences PLSE Stock Holding History

Vontobel Holding’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20,000	Closed	-$432K	–	1177
2021 Q3	$432K	Hold	20,000	–	–	﹤0.01%	844
2021 Q2	$328K	Hold	20,000	–	–	﹤0.01%	890
2021 Q1	$474K	Hold	20,000	–	–	﹤0.01%	689
2020 Q4	$477K	Buy	+20,000	New	+$318K	﹤0.01%	665

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JMPWA

JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

Vontobel Holding's PLSE Position: Q4 2021 in Review

Vontobel Holding sold out of Pulse Biosciences (PLSE) in Q4 2021, closing a stake of 20,000 shares — an estimated $432K sold.

Vontobel Holding first reported a position in PLSE in Q4 2020 and held it in 4 quarters. The position peaked at $477K in Q4 2020. 48 funds tracked by Wall St. Rank hold PLSE as of Q4 2021.

Vontobel Holding reported no remaining Pulse Biosciences position as of Q4 2021 after selling out during the quarter.
Vontobel Holding sold 20,000 Pulse Biosciences shares in Q4 2021, an estimated $432K.
Vontobel Holding first reported a position in Pulse Biosciences in Q4 2020 and held it in 4 quarters.
Vontobel Holding's Pulse Biosciences position peaked at $477K in Q4 2020.
48 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2021.

Based on Vontobel Holding's 13F filing for Q4 2021, filed 10 Feb 2022.